Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
10.1136/ard.2009.118935
October 22, 2009
Rheumatoid arthritis
Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial
10.1136/ard.2009.119149
October 12, 2009
The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3- and 6-month response rates in trials of biological agents
10.1136/ard.2009.115832
September 22, 2009
Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis
10.1136/ard.2009.110650
August 11, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
10.1136/ard.2008.105064
May 4, 2009
Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis
10.1136/ard.2008.106161
April 14, 2009
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
10.1136/ard.2008.105197
March 17, 2009
Dyslipidaemia, statins and rheumatoid arthritis
10.1136/ard.2008.104497
March 13, 2009
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
10.1136/ard.2008.090548
January 15, 2009
Interferon β for rheumatoid arthritis: new clothes for an old kid on the block
10.1136/ard.2008.097899
January 12, 2009